Stock Track | Burning Rock Biotech Surges 5.9% as CFO Resigns, Replacement Named

Stock Track
2024/09/27

Shares of Burning Rock Biotech Limited (NASDAQ: BNR), a company focused on applying next-generation sequencing (NGS) technology in precision oncology, surged 5.9% on Friday after the company announced changes to its management and board of directors.

The company disclosed that its Chief Financial Officer, Leo Li, has resigned from his position and as a member of the board of directors, effective September 27, 2024. Burning Rock stated that Li's resignation was for personal reasons and not due to any disagreement with the board or issues with the company's operations or practices.

To ensure a smooth transition, Burning Rock has appointed Xiaozhi Hu, the current senior director in finance, to oversee the company's financial operations, financial reporting, and related matters. Hu will report directly to Yusheng Han, the chairman of the board and chief executive officer. The company praised Hu's extensive experience in financial management, having joined Burning Rock in May 2014.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10